-
Je něco špatně v tomto záznamu ?
Cutoff Values of MASK-air Patient-Reported Outcome Measures
B. Sousa-Pinto, A. Sá-Sousa, RJ. Vieira, R. Amaral, AM. Pereira, JM. Anto, L. Klimek, W. Czarlewski, J. Mullol, O. Pfaar, A. Bedbrook, L. Brussino, V. Kvedariene, DE. Larenas-Linnemann, Y. Okamoto, MT. Ventura, IJ. Ansotegui, S....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- alergická rýma * diagnóza MeSH
- bronchiální astma * epidemiologie terapie MeSH
- hodnocení výsledků péče pacientem MeSH
- lidé MeSH
- průřezové studie MeSH
- rýma * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: In clinical and epidemiological studies, cutoffs of patient-reported outcome measures can be used to classify patients into groups of statistical and clinical relevance. However, visual analog scale (VAS) cutoffs in MASK-air have not been tested. OBJECTIVE: To calculate cutoffs for VAS global, nasal, ocular, and asthma symptoms. METHODS: In a cross-sectional study design of all MASK-air participants, we compared (1) approaches based on the percentiles (tertiles or quartiles) of VAS distributions and (2) data-driven approaches based on clusters of data from 2 comparators (VAS work and VAS sleep). We then performed sensitivity analyses for individual countries and for VAS levels corresponding to full allergy control. Finally, we tested the different approaches using MASK-air real-world cross-sectional and longitudinal data to assess the most relevant cutoffs. RESULTS: We assessed 395,223 days from 23,201 MASK-air users with self-reported allergic rhinitis. The percentile-oriented approach resulted in lower cutoff values than the data-driven approach. We obtained consistent results in the data-driven approach. Following the latter, the proposed cutoff differentiating "controlled" and "partly-controlled" patients was similar to the cutoff value that had been arbitrarily used (20/100). However, a lower cutoff was obtained to differentiate between "partly-controlled" and "uncontrolled" patients (35 vs the arbitrarily-used value of 50/100). CONCLUSIONS: Using a data-driven approach, we were able to define cutoff values for MASK-air VASs on allergy and asthma symptoms. This may allow for a better classification of patients with rhinitis and asthma according to different levels of control, supporting improved disease management.
Allergy and Clinical Immunology Unit Centro Hospitalar e Universitário de Coimbra Coimbra Portugal
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Allergy Department 2nd Pediatric Clinic University of Athens Athens Greece
Center for Rhinology and Allergology Wiesbaden Germany
CIBER Epidemiología y Salud Pública Barcelona Spain
CINTESIS Center for Health Technology and Services Research University of Porto Porto Portugal
Department of Allergology Medical University of Gdańsk Gdansk Poland
Department of Allergy and Immunology Hospital Quironsalud Bizkaia Bilbao Spain
Department of Allergy ARIA and MASK air Montpellier France
Department of Biomedical Sciences Humanitas University Pieve Emanuele Milan Italy
Department of Epidemiology of Asthma Universitat Pompeu Fabra Barcelona Spain
Department of Immunoallergology Cova da Beira University Hospital Centre Covilhã Portugal
Department of Internal Medicine Poltava State Medical University Poltava Ukraine
Department of Medical Research and Environment IMIM Barcelona Spain
Department of Otolaryngology Head and Neck Surgery Dar Al Shifa Hospital Salmiya Kuwait
Department of Otolaryngology Head and Neck Surgery Eye and Ear University Hospital Beirut Lebanon
Department of Otolaryngology Head and Neck Surgery Universitätsmedizin Mainz Mainz Germany
Department of Otorhinolaryngology Amsterdam University Medical Centres AMC Amsterdam the Netherlands
Department of Otorhinolaryngology Chiba University Hospital and Chiba Rosai Hospital Chiba Japan
Department of Otorhinolaryngology Head and Neck Surgery Semmelweis University Budapest Hungary
Department of Pneumology University Hospital Montpellier France
Department of Pulmonary Diseases Celal Bayar University Faculty of Medicine Manisa Turkey
Department of Respiratory Medicine and Tuberculosis University Hospital Brno Czech Republic
Department Recherches and Développement KYomed INNOV Montpellier France
Ecole Polytechnique Palaiseau IRBA Bretigny France
ENT Department Eskisehir Osmangazi University Medical Faculty Eskisehir Turkey
Fundaçao ProAR Federal University of Bahia and GARD WHO Planning Group Salvador Bahia Brazil
Fundacion Jimenez Diaz CIBERES Faculty of Medicine Autonoma University of Madrid Madrid Spain
IMSB Medical Faculty University at Cologne and ClinCompetence Cologne GmbH Cologne Germany
Institute of Clinical Medicine and Institute of Health Sciences Vilnius Lithunia
Institute of Immunology Faculty of Medicine University of Coimbra Coimbra Portugal
International Primary Care Respiratory Group IPCRG Aberdeen Scotland
Medical Consulting Czarlewski Levallois and MASK air Montpellier France
Medical Faculty of Vilnius University Vilnius Lithuania
Personalized Medicine Asthma and Allergy Humanitas Clinical and Research Center IRCCS Rozzano Italy
RISE Health Research Network University of Porto Porto Portugal
School of Medicine University CEU San Pablo Madrid Spain
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
Skin and Allergy Hospital Helsinki University Hospital University of Helsinki Helsinki Finland
SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010583
- 003
- CZ-PrNML
- 005
- 20230801132520.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jaip.2022.12.005 $2 doi
- 035 __
- $a (PubMed)36566778
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sousa-Pinto, Bernardo $u MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal; RISE-Health Research Network, University of Porto, Porto, Portugal
- 245 10
- $a Cutoff Values of MASK-air Patient-Reported Outcome Measures / $c B. Sousa-Pinto, A. Sá-Sousa, RJ. Vieira, R. Amaral, AM. Pereira, JM. Anto, L. Klimek, W. Czarlewski, J. Mullol, O. Pfaar, A. Bedbrook, L. Brussino, V. Kvedariene, DE. Larenas-Linnemann, Y. Okamoto, MT. Ventura, IJ. Ansotegui, S. Bosnic-Anticevich, GW. Canonica, V. Cardona, L. Cecchi, T. Chivato, C. Cingi, EM. Costa, AA. Cruz, S. Del Giacco, P. Devillier, WJ. Fokkens, B. Gemicioglu, T. Haahtela, JC. Ivancevich, P. Kuna, I. Kaidashev, H. Kraxner, D. Laune, R. Louis, M. Makris, R. Monti, M. Morais-Almeida, R. Mösges, M. Niedoszytko, NG. Papadopoulos, V. Patella, N. Pham-Thi, FS. Regateiro, S. Reitsma, PW. Rouadi, B. Samolinski, A. Sheikh, M. Sova, L. Taborda-Barata, S. Toppila-Salmi, J. Sastre, I. Tsiligianni, A. Valiulis, A. Yorgancioglu, M. Zidarn, T. Zuberbier, JA. Fonseca, J. Bousquet
- 520 9_
- $a BACKGROUND: In clinical and epidemiological studies, cutoffs of patient-reported outcome measures can be used to classify patients into groups of statistical and clinical relevance. However, visual analog scale (VAS) cutoffs in MASK-air have not been tested. OBJECTIVE: To calculate cutoffs for VAS global, nasal, ocular, and asthma symptoms. METHODS: In a cross-sectional study design of all MASK-air participants, we compared (1) approaches based on the percentiles (tertiles or quartiles) of VAS distributions and (2) data-driven approaches based on clusters of data from 2 comparators (VAS work and VAS sleep). We then performed sensitivity analyses for individual countries and for VAS levels corresponding to full allergy control. Finally, we tested the different approaches using MASK-air real-world cross-sectional and longitudinal data to assess the most relevant cutoffs. RESULTS: We assessed 395,223 days from 23,201 MASK-air users with self-reported allergic rhinitis. The percentile-oriented approach resulted in lower cutoff values than the data-driven approach. We obtained consistent results in the data-driven approach. Following the latter, the proposed cutoff differentiating "controlled" and "partly-controlled" patients was similar to the cutoff value that had been arbitrarily used (20/100). However, a lower cutoff was obtained to differentiate between "partly-controlled" and "uncontrolled" patients (35 vs the arbitrarily-used value of 50/100). CONCLUSIONS: Using a data-driven approach, we were able to define cutoff values for MASK-air VASs on allergy and asthma symptoms. This may allow for a better classification of patients with rhinitis and asthma according to different levels of control, supporting improved disease management.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a průřezové studie $7 D003430
- 650 12
- $a alergická rýma $x diagnóza $7 D065631
- 650 12
- $a rýma $7 D012220
- 650 12
- $a bronchiální astma $x epidemiologie $x terapie $7 D001249
- 650 _2
- $a hodnocení výsledků péče pacientem $7 D000071066
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sá-Sousa, Ana $u MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal; RISE-Health Research Network, University of Porto, Porto, Portugal
- 700 1_
- $a Vieira, Rafael José $u MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal; RISE-Health Research Network, University of Porto, Porto, Portugal
- 700 1_
- $a Amaral, Rita $u MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal; RISE-Health Research Network, University of Porto, Porto, Portugal
- 700 1_
- $a Pereira, Ana Margarida $u MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal; RISE-Health Research Network, University of Porto, Porto, Portugal
- 700 1_
- $a Anto, Josep M $u Department of Research & Development, ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain; Department of Medical Research & Environment, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Department of Epidemiology of Asthma, Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
- 700 1_
- $a Klimek, Ludger $u Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany; Center for Rhinology and Allergology, Wiesbaden, Germany
- 700 1_
- $a Czarlewski, Wienczyslawa $u Medical Consulting Czarlewski, Levallois and MASK-air, Montpellier, France
- 700 1_
- $a Mullol, Joaquim $u Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain
- 700 1_
- $a Pfaar, Oliver $u Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany
- 700 1_
- $a Bedbrook, Anna $u Department of Allergy, ARIA & MASK-air, Montpellier, France
- 700 1_
- $a Brussino, Luisa $u Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino and Mauriziano Hospital, Torino, Italy
- 700 1_
- $a Kvedariene, Violeta $u Department of Pathology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
- 700 1_
- $a Larenas-Linnemann, Desirée E $u Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico
- 700 1_
- $a Okamoto, Yoshitaka $u Department of Otorhinolaryngology, Chiba University Hospital and Chiba Rosai Hospital, Chiba, Japan
- 700 1_
- $a Ventura, Maria Teresa $u Unit of Geriatric Immunoallergology, University of Bari Medical School and Institute of Sciences of Food Production, National Research Council (Ispa-Cnr), Bari, Italy
- 700 1_
- $a Ansotegui, Ignacio J $u Department of Allergy and Immunology, Hospital Quironsalud Bizkaia, Bilbao, Spain
- 700 1_
- $a Bosnic-Anticevich, Sinthia $u Quality Use of Respiratory Medicines Group, Woolcock Institute of Medical Research, Sydney, Sydney Pharmacy School, The University of Sydney, Sydney Local Health District, Sydney, NSW, Australia
- 700 1_
- $a Canonica, G Walter $u Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy
- 700 1_
- $a Cardona, Victoria $u Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron & ARADyAL research network, Barcelona, Spain
- 700 1_
- $a Cecchi, Lorenzo $u SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy
- 700 1_
- $a Chivato, Tomas $u School of Medicine, University CEU San Pablo, Madrid, Spain
- 700 1_
- $a Cingi, Cemal $u ENT Department, Eskisehir Osmangazi University, Medical Faculty, Eskisehir, Turkey
- 700 1_
- $a Costa, Elísio M $u UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal
- 700 1_
- $a Cruz, Alvaro A $u Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Bahia, Brazil
- 700 1_
- $a Del Giacco, Stefano $u Department of Medical Sciences and Public Health and Unit of Allergy and Clinical Immunology, University Hospital "Duilio Casula", University of Cagliari, Cagliari, Italy
- 700 1_
- $a Devillier, Philippe $u VIM Suresnes, UMR 0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France
- 700 1_
- $a Fokkens, Wytske J $u Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, the Netherlands
- 700 1_
- $a Gemicioglu, Bilun $u Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey
- 700 1_
- $a Haahtela, Tari $u Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
- 700 1_
- $a Ivancevich, Juan Carlos $u Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina
- 700 1_
- $a Kuna, Piotr $u Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland
- 700 1_
- $a Kaidashev, Igor $u Department of Internal Medicine, Poltava State Medical University, Poltava, Ukraine
- 700 1_
- $a Kraxner, Helga $u Department of Otorhinolaryngology, Head and Neck Surgery, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Laune, Daniel $u Department Recherches & Développement, KYomed INNOV, Montpellier, France
- 700 1_
- $a Louis, Renaud $u Department of Pulmonary Medicine, CHU Liege, and GIGA I3 research group, University of Liege, Liege, Belgium
- 700 1_
- $a Makris, Michael $u Allergy Unit "D Kalogeromitros", 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Greece
- 700 1_
- $a Monti, Riccardo $u Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Morais-Almeida, Mario $u Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal
- 700 1_
- $a Mösges, Ralph $u IMSB, Medical Faculty, University at Cologne, and ClinCompetence Cologne GmbH, Cologne, Germany
- 700 1_
- $a Niedoszytko, Marek $u Department of Allergology, Medical University of Gdańsk, Gdansk, Poland
- 700 1_
- $a Papadopoulos, Nikolaos G $u Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece
- 700 1_
- $a Patella, Vincenzo $u Division of Allergy and Clinical Immunology, Department of Medicine, Agency of Health ASL Salerno, "Santa Maria della Speranza" Hospital, Battipaglia, Salerno, Italy
- 700 1_
- $a Pham-Thi, Nhân $u Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France
- 700 1_
- $a Regateiro, Frederico S $u Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (ICBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- 700 1_
- $a Reitsma, Sietze $u Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, the Netherlands
- 700 1_
- $a Rouadi, Philip W $u Department of Otolaryngology-Head and Neck Surgery, Eye and Ear University Hospital, Beirut, Lebanon; Department of Otolaryngology-Head and Neck Surgery, Dar Al Shifa Hospital, Salmiya, Kuwait
- 700 1_
- $a Samolinski, Boleslaw $u Department of Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland
- 700 1_
- $a Sheikh, Aziz $u Usher Institute, the University of Edinburgh, Edinburgh, UK
- 700 1_
- $a Sova, Milan $u Department of Respiratory Medicine and Tuberculosis, University Hospital, Brno, Czech Republic
- 700 1_
- $a Taborda-Barata, Luis $u UBIAir-Clinical & Experimental Lung Centre, University of Beira Interior, Covilhã and CICS-Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; Department of Immunoallergology, Cova da Beira University Hospital Centre, Covilhã, Portugal
- 700 1_
- $a Toppila-Salmi, Sanna $u Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
- 700 1_
- $a Sastre, Joaquin $u Fundacion Jimenez Diaz, CIBERES, Faculty of Medicine, Autonoma University of Madrid, Madrid, Spain
- 700 1_
- $a Tsiligianni, Ioanna $u Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece; International Primary Care Respiratory Group IPCRG, Aberdeen, Scotland
- 700 1_
- $a Valiulis, Arunas $u Institute of Clinical Medicine and Institute of Health Sciences, Vilnius, Lithunia; Medical Faculty of Vilnius University, Vilnius, Lithuania
- 700 1_
- $a Yorgancioglu, Arzu $u Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa, Turkey
- 700 1_
- $a Zidarn, Mihaela $u University Clinic of Respiratory and Allergic Diseases, Golnik & University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
- 700 1_
- $a Zuberbier, Torsten $u Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany
- 700 1_
- $a Fonseca, Joao A $u MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal; RISE-Health Research Network, University of Porto, Porto, Portugal
- 700 1_
- $a Bousquet, Jean $u Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany; Department of Pneumology, University Hospital, Montpellier, France. Electronic address: jean.bousquet@orange.fr
- 773 0_
- $w MED00201300 $t The journal of allergy and clinical immunology. In practice $x 2213-2201 $g Roč. 11, č. 4 (2023), s. 1281-1289.e5
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36566778 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132516 $b ABA008
- 999 __
- $a ok $b bmc $g 1963173 $s 1196848
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 11 $c 4 $d 1281-1289.e5 $e 20221222 $i 2213-2201 $m The journal of allergy and clinical immunology. In practice $n J Allergy Clin Immunol Pract $x MED00201300
- LZP __
- $a Pubmed-20230718
